Revolution Medicines Inc.-28RVMDWPreferred / convertible
13F holders, Q2 2026 (June 30)22holders −1
3new positions
4sold out
1famous investor
$10.34avg. 13F price*
At the end of Q2 2026, 22 institutions reported holding Revolution Medicines Inc.-28 (RVMDW) in their 13F filings, down 1 from Q1 2026. 3 opened new positions and 4 sold out. The largest holders were LMR Partners LLP ($47.5M), D. E. Shaw & Co. ($14.9M) and Sculptor Capital LP ($6.7M). One famous investor held it David E. Shaw ( of D. E. Shaw & Co.'s portfolio).
- Company
- Revolution Medicines Inc.-28
- CUSIP
- 76155X118
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2026 → Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $5.6M |
| Exits | 4 | $2.1M |
All 13F filers, Q1 2026 → Q2 2026: 1,487,808 shares bought and 1,458,951 shares sold, net +28,857 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 22 holders
| LMR Partners LLP | — | Add +32.0% | 5,066,598 | $47.5M |
| D. E. Shaw & Co. | — | No change | 1,580,345 | $14.9M |
| Sculptor Capital LP | — | Reduce -26.0% | 709,670 | $6.7M |
| CSS LLC | — | Add +347.7% | 78,367 | $6.6M |
| T. Rowe Price Associates Inc. | — | No change | 579,550 | $5.4M |
| Caption Management, LLC | — | No change | 517,685 | $4.9M |
| Adage Capital Partners Gp, L.L.C. | — | No change | 500,000 | $4.7M |
| Rangeley Capital, LLC | — | New | 25,000 | $4.7M |
| Perceptive Advisors LLC | — | No change | 250,000 | $2.3M |
| Bleichroeder LP | — | No change | 200,000 | $1.9M |
| Wolverine Asset Management LLC | — | Reduce -9.5% | 154,544 | $1.4M |
| Farallon Capital Management, L.L.C. | — | No change | 120,085 | $1.1M |
| Warberg Asset Management LLC | — | New | 94,797 | $889K |
| Weiss Asset Management LP | — | No change | 73,640 | $692K |
| TD Asset Management Inc | — | No change | 40,636 | $382K |
| Driehaus Capital Management LLC | — | No change | 20,000 | $188K |
| UBS Group AG | — | Add +177.8% | 2,461 | $23K |
| Morgan Stanley | — | No change | 2,216 | $21K |
| DLK Investment Management, LLC | — | New | 77,000 | $8K |
| TD Waterhouse Canada Inc. | — | No change | 448 | $4K |
| Royal Bank of Canada | — | No change | 200 | $2K |
| Osaic Holdings, Inc. | — | Reduce -33.3% | 60 | $562 |
"% of holder's portfolio" is RVMDW's weight in each manager's 13F, not the share of Revolution Medicines Inc.-28 the manager owns.